Cogent Biosciences, Inc. (COGT): Depreciation & Amortization
$2.60M
Year ended 2025-12-31
$2.67M
Trailing 12 months to 2026-06-30
+48.1%
3-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.60M | +4.0% | 2026-02-17, From 2025-01-01 |
| 2024-12-31 | $2.50M | +8.7% | 2026-02-17, From 2024-01-01 |
| 2023-12-31 | $2.30M | +187.5% | 2026-02-17, From 2023-01-01 |
| 2022-12-31 | $800.0K | n/c | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $147.0K | -79.6% | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $720.0K | -44.3% | 2022-03-15, From 2020-01-01 |
| 2019-12-31 | $1.29M | -2.1% | 2021-03-16, From 2019-01-01 |
| 2018-12-31 | $1.32M | +12.8% | 2020-03-26, From 2018-01-01 |
| 2017-12-31 | $1.17M | n/a | 2019-03-28, From 2017-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | 2025-12-31 | $2.60M | +4.0% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $5.43M | -10.6% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $460.0K | -14.8% |
| Xencor Inc (XNCR) | 2025-12-31 | $10.51M | -13.2% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $24.24M | +2.6% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $1.15M | +44.5% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $59.0K | -13.2% |
| uniQure N.V. (QURE) | 2025-12-31 | $14.76M | +16.8% |
| Vireo Growth Inc. (VREOF) | 2025-12-31 | $16.11M | +535.0% |
Compare COGT, BBIO, VRDN, XNCR side by side · Screen every company in Pharmaceutical Preparations ↗